2023 Medicare Prescription Drug Pricing 
Health Law Advisor
MARCH 7, 2023
This feedback must be submitted to CMS by March 11, 2023 via email ( IRARebateandNegotiation@cms.hhs.gov ). Stakeholders can view CMS’s issuance of the Initial Inflation Rebate Guidances as an early step in the complex, multi-year process CMS must undertake to implement the various IRA provisions.
Jane Sarashon
FEBRUARY 27, 2024
In addition to highlighting the Patient’s Bill of Rights, NABIP’s keynotes and general sessions will speak to similar topics being brainstormed at VIVE this week — including mental health, maternal health, pharmacy and prescription drugs (pricing, PBMs), population health, and Medicare and Medicaid innovations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Care Law Brief
JANUARY 19, 2022
On December 31, 2021, New York Governor Kathy Hochul signed landmark legislation to increase the transparency of prescription drug pricing and to establish requirements on pharmacy middlemen. Failure to obtain a license by 2023 could result in a cease and desist order from DFS and financial penalties. 1] [link].
Health Law Advisor
MAY 22, 2023
1339) reflects the overarching legislative push by members from both sides of the aisle and chambers of Congress to address drug pricing issues through federal fixes to the PBM framework. An Overview of the Proposed Legislation On May 2, 2023, the HELP Committee marked up S. 1339 the Committee passed last week.
Healthcare It News
APRIL 28, 2022
"With prescription drug prices rising at every turn, patients need price transparency and the ability to discuss options with their doctors during office visits," Davis advised. ADVICE FOR OTHERS.
Health Populi
DECEMBER 6, 2023
voters’ minds among many issues Americans are feeling and following in late 2023. adults between October 31 and November 7, 2023, via online and phone. The future of Medicare and Medicaid as well as access to mental health care also rank high among two-thirds of U.S. The cost of living ranks top in U.S.
Jane Sarashon
JULY 18, 2024
We’ve discussed the hockey-stick rise in the adoption and persistent use of GLP-1 drugs for managing diabetes and obesity here in Health Populi. This graph diagrams utilization, unit cost, and cost as a percent of overall medical cost trend: note that by the middle of 2023, GLP-1 drug costs for Group health plan members comprised 13.6%
Expert insights. Personalized for you.
52 
Let's personalize your content